Hagens Berman Reminds Roadrunner Transportation Systems,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Hagens Berman Reminds Roadrunner Transportation Systems, Inc. (NYSE:RRTS) Investors With Losses Over $50,000 of January 19, 2016 Lead Plaintiff Deadline

SAN FRANCISCO, Dec. 28, 2015 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors with losses over $50,000 of the January 19, 2016 lead plaintiff deadline in the securities fraud class action lawsuit filed against Roadrunner Transportation Systems, Inc. (NYSE: RRTS ).

If you suffered losses because of your purchase of Roadrunner securities between July 30, 2015 and October 26, 2015 , contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000, emailing RRTS@hbsslaw.com or visiting http://www.hbsslaw.com/cases/RRTS . The lawsuit was filed in the U.S. District Court for the Eastern District of New York and investors have until January 19, 2016 to move the court to act as lead plaintiff . Following the Company’s October 26, 2015 announcement that poultry, beef and produce freight were lower than expected due to the Midwest and West Coast droughts and the bird flu epidemic, the value of Roadrunner shares declined substantially, closing at $9.34, down $8.33 on the next trading day. The share price has not recovered.

The complaint alleges that Roadrunner violated the securities laws because they failed to disclose the potential impact that the drought and the avian flu epidemic would have on their financial condition. As a result, the Company's statements about its business, operations, and prospects were materially false and misleading.

Whistleblowers: Persons with non-public information regarding Roadrunner should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email RRTS@hbsslaw.com .

About Hagens Berman Hagens Berman is headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com . Read the Firm’s Securities Newsletter , and visit the blog . For the latest news visit our newsroom or follow us on Twitter at @classactionlaw .

Contact: Reed Kathrein, 510-725-3000

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Market Expansion of Utility Solar Trackers: Future Insights

Updated Category News Views 247

Utility Solar Tracker Market Growth Prospects The utility solar tracker market is projected to reach an impressive USD 34.6 billion in the coming years. This growth is largely driven by the declining costs of photovoltaic (PV) panels, which have significantly lowered the financial barriers for solar energy projects. As PV panels become more affordable, the opportunity for...

Continue Reading
UVA Cancer Center Joins Caris Precision Oncology Alliance

Updated Category News Views 59

UVA Cancer Center Joins the Caris Precision Oncology Alliance UVA Cancer Center has officially joined the Caris Precision Oncology Alliance (Caris POA), a significant network dedicated to advancing precision medicine and cancer treatment. Caris Life Sciences is thrilled to welcome this esteemed institution, recognized for its commitment to enhancing patient outcomes...

Continue Reading
Investors Show Strong Confidence in Spotify Technology's Future Potential

Updated Category News Views 116

High-Rolling Investors Stake Their Bets on Spotify Technology In recent developments, it's evident that significant investors have adopted a bullish stance on Spotify Technology. This movement warrants attention from retail traders and those interested in stock market dynamics. Overview of Options Activity Tracking the latest trends, we've noted a remarkable surge in...

Continue Reading
Johnson & Johnson's Groundbreaking CAR T-Cell Therapy Data Unveiled

Updated Category News Views 191

Johnson & Johnson’s CAR T-Cell Therapy Demonstrates Promise in Lymphoma In a recent Phase 1b study, Johnson & Johnson (NYSE: JNJ) revealed the first clinical results of its investigational dual-targeting CAR T-cell therapy, JNJ-90014496, specifically aimed at treating patients with relapsed or refractory large B-cell lymphoma (R/R LBCL). This early data suggests a...

Continue Reading
Booking Holdings Prepares for Upcoming Earnings Report

Updated Category News Views 143

Booking Holdings Set for Earnings Announcement Booking Holdings (NASDAQ: BKNG) is gearing up to share its quarterly earnings. Investors are keenly awaiting this announcement, which is expected to be significant for market sentiment and share price movements. Expected Earnings Per Share According to analysts, Booking Holdings is projected to report an impressive earnings...

Continue Reading